4//SEC Filing
LANKLER DOUGLAS M 4
Accession 0001225208-24-003053
CIK 0000078003other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 1:46 PM ET
Size
10.9 KB
Accession
0001225208-24-003053
Insider Transaction Report
Form 4
PFIZER INCPFE
LANKLER DOUGLAS M
Senior Vice President
Transactions
- Exercise/Conversion
Common Stock
2024-02-23$27.34/sh+95,755$2,617,942→ 230,920 total - Tax Payment
Common Stock
2024-02-23$27.76/sh−6,618$183,716→ 224,302 total - Tax Payment
Common Stock
2024-02-23$27.37/sh−77,384$2,118,000→ 146,918 total - Exercise/Conversion
Stock Appreciation Rights
2024-02-23−95,755→ 0 totalExercise: $27.34From: 2024-02-23Exp: 2024-02-23→ Common Stock (95,755 underlying)
Holdings
- 1,832(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (4)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001488270
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 1:46 PM ET
- Size
- 10.9 KB